Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

accord healthcare polska sp. z o.o., varšava array - 3360 mitomycin - prášek pro injekční/infuzní roztok - 40mg - mitomycin

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

accord healthcare polska sp. z o.o., varšava array - 110 monohydrÁt atropin-sulfÁtu - injekční roztok v předplněné injekční stříkačce - 0,1mg/ml - atropin

Euroopa Liit - tšehhi - EMA (European Medicines Agency)

novartis europharm ltd. - aliskiren - hypertenze - agens působící na systém renin-angiotenzin - léčba esenciální hypertenze.

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

b. braun melsungen ag, melsungen array - 4808 monohydrÁt kalcium-glukonÁtu pro injekci - injekční roztok - 10% - kalcium-glukonÁt

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

septodont ou septodont sas ou specialites septodont, saint-maur-des-fosses array - 904 mepivakain-hydrochlorid - injekční roztok - 30mg/ml - mepivakain

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

bayer ag, leverkusen array - 4289 testosteron-undekanoÁt - injekční roztok - 1000mg/4ml - testosteron

Euroopa Liit - tšehhi - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. použití této vakcíny musí být v souladu s oficiálními doporučeními.

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

teva b.v., haarlem nizozemsko - 18165 ikatibant-acetÁt - injekční roztok v předplněné injekční stříkačce - 30mg - ikatibant

Tšehhi - tšehhi - SUKL (Státní ústav pro kontrolu léčiv)

takeda gmbh, konstanz array - 15923 sodnÁ sŮl pantoprazolu - prášek pro injekční roztok - 40mg - pantoprazol

Euroopa Liit - tšehhi - EMA (European Medicines Agency)

eli lilly nederland b.v. - inzulín lispro - diabetes mellitus - léky užívané při diabetu - léčba diabetes mellitus u dospělých, dospívajících a dětí ve věku 1 roku a starší. léčba diabetes mellitus u dospělých.